Eli Lilly has paid more than $1 billion to settle legal battles over its top-selling drug Zyprexa, and it might have to write another large check soon. But a new lawsuit says the company should have known better. Two shareholders have sued Lilly in federal court in Indiana, accusing Lilly executives and directors of recklessly disregarding risks posed by illegal drug marketing tactics, which have been alleged in lawsuits and newspaper articles. A Lilly spokesman calls the lawsuit "groundless."
February 01, 2008 at 12:00 AM
1 minute read
The original version of this story was published on National Law Journal
Eli Lilly and Co. has paid more than $1 billion to settle legal battles over its top-selling drug Zyprexa, and it might have to write another large check soon. But a new lawsuit says the company should have known better.
Two shareholders have accused Lilly executives and directors of recklessly disregarding risks posed by illegal drug marketing tactics, which have been alleged in lawsuits and newspaper articles.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
